PubMed HealthSearch

PubMed · 7987038

Abdominal aortic aneurysms.

Abstract

The management of abdominal aortic aneurysms has undergone tremendous evolution during the past three decades, resulting in significant advances in our ability to diagnose and safety treat patients with aneurysms. Over the past several years, most research interest has been focused on the etiology of aneurysmal disease, new imaging techniques, cardiac risk stratification, and new approaches for treatment. This article reviews the current approach to diagnosing and treating patients with abdominal aortic aneurysms as well as the results which may be anticipated. In stark contrast to the treatment of nonruptured aortic aneurysms, little progress has been made in the management of ruptured aneurysms, which remain highly lethal. Early identification, prompt evaluation, and surgical repair remain the most important elements in preventing mortality.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Belkin, M C Donaldson, A D Whittemore. 1994. Abdominal aortic aneurysms.. https://doi.org/10.1097/00001573-199409000-00013

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Comprehensive evaluation of differential expression of piRNAs in abdominal aortic aneurysm.

Abdominal aortic aneurysm (AAA) is a prevalent and fatal cardiovascular condition characterized by a high incidence rate and nonspecific clinical manifestations, with no effective preventive or therapeutic measures currently available. Piwi-interacting RNAs (piRNAs) have been identified as significant biomarkers for disease diagnosis due to their essential functions in transposon suppression, maintenance of genomic stability, immune response, and epigenetic modulation. The piRNA is intimately associated with various diseases such as cardiac hypertrophy, tumors, and neurodegeneration, yet its role in AAA is unclear. In this study, we employed gene sequencing to analyze the piRNA expression profiles in AAA vascular tissues and predicted variations in their target genes. Our findings revealed a total of 1368 piRNAs with abnormal expression in the AAA group relative to the control group, including 1240 up-regulated and 128 down-regulated piRNAs (|log2(fold change)|&#xa0;&#x2265;&#xa0;1.0), with 82 demonstrating significant differences (P&#xa0;<&#xa0;0.05). Through bioinformatics analysis, it was determined that the Wnt signaling pathway, calcium signaling, TNF-&#x3b1; and the p53 pathway are crucial mechanisms by which piRNAs contribute to the development of AAA. RT-qPCR confirmed that hsa_piR_011324 was the most significantly up-regulated piRNA in AAA (P&#xa0;<&#xa0;0.0001), corroborating RNA sequencing results. Further results indicate that hsa_piR_011324 promotes phenotypic transformation of human aortic vascular smooth muscle cells (HAVSMCs), enhances the activity of matrix metalloproteinases (MMPs), increased up-regulation of inflammation-related markers IL-1&#x3b2; and TNF-&#x3b1;, and induces apoptotic processes. In conclusion, the present study emphasizes the important regulatory role of hsa_piR_011324 in AAA, suggesting that it holds promise as a prospective target for diagnostic and therapeutic intervention.

Aortic Aneurysm, Abdominal